Source: Annual Congress 2009 - Antibiotics and the lung



Rating:

Share or cite this content

Citations should be made in the following way:
T. Welte (Hanover, Germany). Do we need new antibiotics?. Annual Congress 2009 - Antibiotics and the lung

Member's Comments

No comment yet.

Related content which might interest you: Do we have any alternative therapeutic option beyond antibiotics? Source: Postgraduate course 2021: PG7 - Postgraduate course : Emerging infectious diseases and antimicrobial resistance: diagnostics, treatments, vaccines and other preventive and/or therapeutic interventions Year: 2021 Do we really need guidelines? Source: Virtual Congress 2020 – Do we really need guidelines? Year: 2020 Therapeutic strategies in pneumonia: going beyond antibiotics Source: Eur Respir Rev 2015; 24: 516-524 Year: 2015 Getting approval for new therapeutic medical devices versus drugs: are the differences justified? Source: Eur Respir Rev 2016; 25: 223-226 Year: 2016 Which patients with COPD can potentially benefit from prophylactic use of antibiotics? Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Who can pay for innovative medicines? Source: Eur Respir J 2013; 41: 495-496 Year: 2013 The challenges of severe pneumonia: new pathogens, new drugs and new formulations Source: Virtual Congress 2021 – Respiratory infections Year: 2021 Are antimicrobials still the future of respiratory infection therapy? Source: Virtual Congress 2021 – Emerging data for the management of respiratory tract infections Year: 2021 What do we need in the clinic and what approach can clinicians take to improve the drug development pipeline? Source: ERS Research Seminar 2016 Year: 2016 Inhaled antibiotics: a new tool? Source: Annual Congress 2009 - Antibiotics and the lung Year: 2009 MDR-TB management: what is new? Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Tuberculosis elimination, patients' lives and rational use of new drugs: revisited Source: Eur Respir J 2016; 47: 664-667 Year: 2016 Do we need new asthma control tests? Source: Eur Respir J 2014; 44: 1116-1118 Year: 2014 HAP/VAP : new guidelines, new approaches Source: International Congress 2018 – Chinese Programme 2018: Part II Year: 2018 Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012 The issues and the controversies: are we really ready for on-demand use of ICS? Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use? Year: 2013